Immune Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
406.60
192.00
23.10
74.40
14.70
5.90
Total Accounts Receivable
-
-
16.20
-
-
-
Inventories
-
-
-
-
178.10
82.80
Other Current Assets
215.90
30.00
-
-
-
-
Total Current Assets
622.50
222.00
39.30
74.40
192.80
88.70
Net Property, Plant & Equipment
5.60
4.20
1.70
1.90
2.50
2.80
Intangible Assets
18,546.50
5,818.60
-
-
-
-
Other Assets
17.40
10.20
0.20
0.20
0.20
0.20
Total Assets
19,192.10
6,055.00
41.20
76.40
195.50
91.60
ST Debt & Current Portion LT Debt
795.70
186.10
2,793.70
4,225.40
4,820.10
Accounts Payable
839.90
-
1,924.70
1,818.60
2,319.90
Other Current Liabilities
804.20
3,189.00
1,281.00
3,156.80
4,158.90
Total Current Liabilities
2,439.70
3,375.10
5,999.40
9,200.80
11,298.90
Long-Term Debt
121.10
327.50
-
-
-
Total Liabilities
2,560.80
3,702.60
5,999.40
9,200.80
11,298.90
Common Equity (Total)
16,631.20
1,745.90
5,929.00
5,134.00
6,494.80
Total Shareholders' Equity
16,631.20
1,745.90
5,929.00
5,134.00
6,494.80
Total Equity
16,631.20
2,352.40
5,958.20
9,124.30
11,103.40
Liabilities & Shareholders' Equity
19,192.10
6,055.00
41.20
76.40
195.50
Accumulated Minority Interest
-
606.50
29.20
3,990.40
4,608.60
About Immune Therapeutics
View Profile
